Skip to main content

MACKENZIE FINANCIAL CORP

Position in DXCM — Dexcom Inc

CIK 919859 TORONTO ONTARIO, A6

Position in DXCM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,273,472
-$62,334,274 QoQ
Shares Held
197,082
-83.6% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#176
of 971 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DXCM Over Time

Shares Held

Position Value (USD)

Derivatives in DXCM

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$45,880
PutShares
14,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

MACKENZIE FINANCIAL CORP holds $483,618,661 across 20 Medical Devices names. DXCM ranks #5 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 DXCM
Dexcom Inc
This page
197,082 $13,273,472

All Filings in DXCM

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $45,880 14,800
2026-06-30 $13,273,472 197,082
2026-03-31 $75,607,746 1,203,945
2025-12-31 $80,438,050 1,211,964
2025-09-30 $74,398,784 1,105,644
2025-06-30 $88,863,053 1,018,021
2025-03-31 $72,473,855 1,061,266
2024-12-31 $100,850,425 1,296,778
2024-09-30 $86,841,671 1,295,371
2024-06-30 $93,106,748 821,192
2024-03-31 $103,569,925 746,719
2023-12-31 $93,024,316 749,652
2023-09-30 $61,001,685 653,823
2023-06-30 $64,289,312 500,267
2023-03-31 $61,734,915 531,373
2022-12-31 $62,778,217 554,382
2022-09-30 $41,741,787 518,274
2022-06-30 $32,614,029 437,596
2022-03-31 $15,100,385 29,516
2021-12-31 $12,541,004 23,356
2021-09-30 $10,739,236 19,638
2021-06-30 $8,024,611 18,793
2021-03-31 $6,438,831 17,916
2020-12-31 $6,058,231 16,386
2020-09-30 $6,088,224 14,769
2020-06-30 $7,062,878 17,422
2020-03-31 $4,924,140 18,287